In this study, researchers aimed to determine whether younger BRCA1/2 carriers who undergo oophorectomy can receive menopausal hormone therapy without increasing their risk of breast cancer.

A recent study by the ICMR National Centre for Disease Informatics and Research warns of a 5.6% annual increase in Indian breast cancer cases, driven by various risk factors.

Kolkata: The Kolkata Gynaecological Oncology Trials and Translational Research Group received ICMR funding for the clinical ...

A pioneering study has found that an individualized approach to breast cancer screening that assesses patients' risk, rather ...

Actress Angelina Jolie shares her mastectomy scars 10 years on, spotlighting genetic risk, early detection, and the ...

Angelina Jolie reveals why she chose a preventive double mastectomy to reduce her cancer risk Here’s a detailed look at her ...

Hormone replacement therapy (HRT) does not increase breast cancer risk in BRCA1/BRCA2 carriers, with estrogen-alone formulations showing a lower risk. The study used a matched-pair design to control ...

The U.S. Food and Drug Administration has granted regular approval to treatment with Rubraca (rucaparib) for the treatment of ...

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

Mr. Sasse, a former senator from Nebraska, announced that he had received a diagnosis last week for Stage 4 pancreatic cancer ...

Advancements in understanding tumor biology, identifying predictive biomarkers, and developing targeted therapies have ...